↓ Skip to main content
What is this page? Embed badge

Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

Overview of attention for article published in Journal of Clinical Oncology, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

policy
1 policy source
twitter
10 X users
peer_reviews
1 peer review site
weibo
1 weibo user
wikipedia
1 Wikipedia page

Readers on

mendeley
219 Mendeley
Summary Policy documents X Peer reviews Weibo Wikipedia

Hi there!

You are about to view the mentions from Sina Weibo, a major social network in the People's Republic of China. In order for us to show you Sina Weibo mentions we are obliged to comply with certain licensing restrictions. Please read the following message carefully, and provide a response.

Are you:

  • A person (or entity) registered or residing within the People's Republic of China (including Hong Kong, Taiwan, or Macau), or
  • A person (or entity) in the direct employ of a government or governmental agency of any kind?

This page is provided by Altmetric.